Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics
Nat Cardiovasc Res. 2023 Dec;2(12):1246-1261. doi: 10.1038/s44161-023-00370-3. Epub 2023 Dec 7. ABSTRACT Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a fatal genetic heart disease characterized by …